Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11318120 Nuclear transport modulators and uses thereof

Patent 11318120 was granted and assigned to Biogen on May, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Biogen

Current Assignee

Biogen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113181200

Patent Inventor Names

Vincent P. Sandanayaka0

Dilara McCauley0

Erkan Baloglu0

Sharon Shacham0

Sharon Shechter0

Date of Patent

May 3, 2022

Patent Application Number

171795120

Date Filed

February 19, 2021

Patent Citations

‌

US Patent 10407405 Nuclear transport modulators and uses thereof

‌

US Patent 10058535 Nuclear transport modulators and uses thereof

‌

US Patent 10173987 Hydrazide containing nuclear transport modulators and uses thereof

‌

US Patent 10202366 Methods of promoting wound healing using CRM1 inhibitors

‌

US Patent 10335393 Nuclear transport modulators and uses thereof

‌

US Patent 10617677 Nuclear transport modulators and uses thereof

Patent Primary Examiner

CPC Code

Patent abstract

Compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11318120 Nuclear transport modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API